.jpg)
Read entire article here:
" Dr Brad Thompson, president and chief executive of Oncolytics Biotech Inc, the Canadian manufacturers of Reolysin, said: ''We believe that this study clearly demonstrates that the combination of low dose radiation and Reolysin is well tolerated and that the very high response rate warrants further investigation.''
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Only by exercising YOUR freedom of speech shall you keep it. Comment now - I can handle it....
Note: Only a member of this blog may post a comment.